CIRO MFD Rule 2.5.3

Announcement comes as global pharmaceutical markets shift, with Canada facing pressure to secure investments and ensure timely access to new therapies.

Non-US financial institutions are likely to evaluate Cuba-related customers or counterparties more strictly in light of the new secondary sanctions authority.

The proposed rules would give Canadian issuers more room to repurchase shares privately.

The US financial regulator is warning firms across the country to watch for signs of sex and labor trafficking amid heightened local economic activity from the event.

Our in-brief roundup of notable stories from the last week.

Proposed framework would allow Canadian regulator to use drug approval decisions from foreign agencies to speed up approvals in Canada.

Under the new rules, FINTRAC may impose much higher maximum penalties and make greater use of formal tools to force firms to fix compliance problems.

Our in-brief roundup of notable stories from the last week.